• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Bipartisan bill seeks to stop pharmacy middlemen from driving up drug costs for financial gain

by March 18, 2025
written by March 18, 2025

A bipartisan group of lawmakers is pushing to reform the incentive structure for Pharmacy Benefit Managers (PBMs), arguing that it drives up patient costs by encouraging them to favor higher-priced drugs while withholding potential savings.

Led by physician and GOP Iowa Rep. Mariannette Miller-Meeks, the group introduced the ‘Delinking Revenue from Unfair Gouging (DRUG) Act’ on Tuesday, requiring that PBMs in the commercial market only charge a flat fee for their services related to a specific prescription drug, versus letting them continue to charge a percentage of the drug price. 

PBMs are third-party intermediaries between insurance companies, drug manufacturers and pharmacies that serve to control drug prices and access. The current incentive structure for PBMs, according to the DRUG Act’s sponsors, encourages them to drive up the list price of drugs to increase profits.    

‘Pharmacy benefit managers (PBMs) have excessive influence over the prices patients pay at the pharmacy counter,’ said Miller-Meeks. ‘Local Iowa pharmacies are closing due to greedy PBM practices, impacting proximity and access to medications for Iowans. The DRUG Act will put downward pressure on prescription drug prices and insurance premiums by removing the incentive for PBMs to drive up the list price of medications.’

According to the Iowa Pharmacy Association, PBMs have been using opaque reimbursement models that often pay back pharmacies less than the list cost of a drug and the services provided to dispense it. 

As a result of these practices, pharmacies in Iowa and across the country have been forced to close, the association said in a January report. Twenty-nine Iowa pharmacies and 2,300 pharmacies nationwide closed their doors in 2024, according to the association.  

While PBMs have played important roles in making drugs more widely available, through decades of mergers and acquisitions, the three largest PBMs now manage nearly 80% of all prescriptions filled in the U.S., according to a 2024 report from the Federal Trade Commission. 

The DRUG Act’s reforms serve to address this anti-competitiveness, which the bill’s sponsors say will also help lower costs.

‘Pharmacy Benefit Managers (PBMs) contribute to high drug costs because they are incentivized to steer patients towards drugs that are more profitable for PBMs, but may be less clinically effective for consumers,’ said Rep. Nannette Barragán, D-Calif., one of the bill’s co-sponsors. ‘This broken system disproportionately harms low-income individuals, seniors, and those with chronic illnesses who rely on life-saving prescriptions to manage their health.’

Rep. Donald Norcross, D-N.J., another co-sponsor of the DRUG Act, said families in his district ‘are crying out for relief from high prescription drug prices.’

‘Americans deserve access to quality health care and affordable prescription drugs,’ Norcross said. ‘The DRUG Act reins in prescription drug prices by removing the incentive for pharmacy benefit managers to drive up costs, increasing transparency and prioritizing patients over profits.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump now speaking with Russia’s Putin about ending Ukraine war
next post
Vance knocks globalization’s ‘cheap labor’ and lauds ‘America’s great industrial comeback’ at AI summit

related articles

Inside Trump’s ultimatum that forced Netanyahu to the...

October 23, 2025

Vance rebukes Israel on ‘very stupid’ vote to...

October 23, 2025

Top Republican slams Katherine Clark for admitting suffering...

October 23, 2025

Vance calls Psaki comments about wife Usha ‘disgraceful’

October 23, 2025

Trump yet to endorse in VA governor’s race...

October 23, 2025

DAVID MARCUS: Trump’s ballroom is no vanity project,...

October 23, 2025

Examining the next threat from Communist China: Our...

October 23, 2025

Sparks fly as Cuomo, Mamdani tear into each...

October 23, 2025

Trump meets NATO’s Rutte amid canceled Putin meeting:...

October 22, 2025

Schumer blocks 12th GOP bid to reopen government...

October 22, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • JD Vance honors his mother at White House for reaching 10 years sobriety

    April 7, 2025
  • I left the Democrat Party and will do all I can to return Donald Trump to the White House

    August 26, 2024
  • Where Vance and Walz favorability ratings stand 60 days to Election Day

    September 5, 2024
  • The S&P 500 and Nasdaq are driving the recovery

    July 30, 2024
  • Israeli forces seize documents that reveal Hamas plan for more elaborate attacks: report

    October 15, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 4

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,503)
  • Investing (634)
  • Stock (941)

Latest Posts

  • Impact of Trump’s Tariffs on Asian Economies

    February 3, 2025
  • Global Markets on Edge as Trump’s Tariff Deadline Nears

    January 31, 2025
  • RFK Jr attributes rise in autism to environmental factors, while CDC points to improved diagnostic practices

    April 16, 2025

Recent Posts

  • Special Counsel Jack Smith required to submit Trump findings to DOJ before leaving. What happens next?

    December 7, 2024
  • IAG Share Price Forecast for 2024: A Comprehensive Analysis

    August 6, 2024
  • World leaders react to Biden’s decision to not seek re-election: ‘deserves respect’

    July 21, 2024

Editor’s Pick

  • AI Shares Drop: US and Asian Markets at a Decline

    July 25, 2024
  • ‘It’s a mess’: Vulnerable House Dem shreds Biden on border crisis in ‘closing message’ of campaign

    October 22, 2024
  • Here’s who Biden blames for his 2024 election loss, Trump divulges after private convo

    February 28, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock